Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Privia Health Group Inc (NASDAQ: PRVA) was $19.53 for the day, up 1.30% from the previous closing price of $19.28. In other words, the price has increased by $1.30 from its previous closing price. On the day, 0.55 million shares were traded. PRVA stock price reached its highest trading level at $20.02 during the session, while it also had its lowest trading level at $19.51.
Ratios:
Our analysis of PRVA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.19. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 30, 2024, initiated with a Outperform rating and assigned the stock a target price of $23.
On April 22, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
On March 06, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $22.Barclays initiated its Equal Weight rating on March 06, 2024, with a $22 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 11 ’24 when Boehler Adam bought 364 shares for $16.50 per share. The transaction valued at 6,006 led to the insider holds 5,773,522 shares of the business.
Boehler Adam bought 5,306 shares of PRVA for $87,549 on May 29 ’24. The Director now owns 5,773,158 shares after completing the transaction at $16.50 per share. On May 24 ’24, another insider, Boehler Adam, who serves as the Director of the company, bought 4,280 shares for $16.49 each. As a result, the insider paid 70,577 and bolstered with 5,767,852 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2335104512 and an Enterprise Value of 1972818688. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 163.57, and their Forward P/E ratio for the next fiscal year is 82.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 3.92. Its current Enterprise Value per Revenue stands at 1.163 whereas that against EBITDA is 98.547.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.80, which has changed by -0.23309469 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $27.34, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is 6.73%, while the 200-Day Moving Average is calculated to be -2.16%.
Shares Statistics:
PRVA traded an average of 811.45K shares per day over the past three months and 679570 shares per day over the past ten days. A total of 118.22M shares are outstanding, with a floating share count of 105.97M. Insiders hold about 11.37% of the company’s shares, while institutions hold 95.28% stake in the company. Shares short for PRVA as of 1722384000 were 5716465 with a Short Ratio of 7.04, compared to 1719532800 on 6650328. Therefore, it implies a Short% of Shares Outstanding of 5716465 and a Short% of Float of 7.6899999999999995.
Earnings Estimates
A comprehensive evaluation of Privia Health Group Inc (PRVA) is underway, with the input of 14.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.05, with high estimates of $0.07 and low estimates of $0.03.
Analysts are recommending an EPS of between $0.2 and $0.11 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.24, with 14.0 analysts recommending between $0.36 and $0.14.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 13 analysts. It ranges from a high estimate of $745.2M to a low estimate of $690.3M. As of the current estimate, Privia Health Group Inc’s year-ago sales were $723.5MFor the next quarter, 13 analysts are estimating revenue of $726.03M. There is a high estimate of $779.3M for the next quarter, whereas the lowest estimate is $693M.
A total of 13 analysts have provided revenue estimates for PRVA’s current fiscal year. The highest revenue estimate was $2.96B, while the lowest revenue estimate was $2.83B, resulting in an average revenue estimate of $2.87B. In the same quarter a year ago, actual revenue was $2.84BBased on 13 analysts’ estimates, the company’s revenue will be $3.23B in the next fiscal year. The high estimate is $3.35B and the low estimate is $3.12B.
